Secondary
Amicus Therapeutics
They are a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases.
Symbol
FOLD
Last Closing Price
$15.83
Effective Date
February 16, 2018
Underwriters
J.P. Morgan, Goldman Sachs, Cowen, Leerink
To view the prospectus for Amicus Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277